Nova Patents
PL3482767T3

Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency

Abstract

This record has no abstract on file.

Term

3.9 yearsto projected expiry

Projected expiry 28 August 2030, counted from filing; an application has no term until it is granted.

  1. Priority
  2. Filed
  3. Published
  4. Today
  5. Projected expiry

127 members in 30 offices

This recordMember, by publication datePriority claim20 more offices are in the list below

Priority claims3

Priority claims
DocumentOfficeKindDate
23811309United States of AmericaP
10812683European Patent Office (EPO)A
2010047057United States of AmericaW

Members127

Family members, oldest first
DocumentOfficeKind
CA2773133A1CanadaA1
US2011052559A1United States of AmericaA1
WO2011025996A2World Intellectual Property Organization (WIPO)A2
WO2011025996A9World Intellectual Property Organization (WIPO)A9
MX2012002449AMexicoA
AU2010286550A1AustraliaA1
WO2011025996A3World Intellectual Property Organization (WIPO)A3
IL218324A0IsraelA0
IL218324D0IsraelD0
EP2470199A2European Patent Office (EPO)A2
CN102596232AChinaA
KR20120081077ARepublic of KoreaA
US8349319B2United States of AmericaB2
JP2013502933AJapanA
EP2470199A4European Patent Office (EPO)A4
US2013078230A1United States of AmericaA1
US2013078231A1United States of AmericaA1
RU2012111823ARussian FederationA
CL2012000495A1ChileA1
US8658162B2United States of AmericaB2
US8709408B2United States of AmericaB2
US2014335070A1United States of AmericaA1
US9114139B2United States of AmericaB2
RU2569744C2Russian FederationC2
US2016120957A1United States of AmericaA1
AU2010286550B2AustraliaB2
JP5955219B2JapanB2
JP2016153408AJapanA
AU2016216625A1AustraliaA1
CN105999238AChinaA
CN106047835AChinaA
US9655954B2United States of AmericaB2
ZA201601362BSouth AfricaB
BR112012004377A2BrazilA2
JP6251307B2JapanB2
US2018055916A1United States of AmericaA1
JP2018076322AJapanA
MX356873BMexicoB
AU2018204156A1AustraliaA1
AU2016216625B2AustraliaB2
RU2015145255ARussian FederationA
US10188705B2United States of AmericaB2
EP3482767A1European Patent Office (EPO)A1
EP2470199B1European Patent Office (EPO)B1
US2019151419A1United States of AmericaA1
IL218324AIsraelA
IL218324BIsraelB
IL266915AIsraelA
IL266915D0IsraelD0
DK2470199T3DenmarkT3
PT2470199TPortugalT
RU2015145255A3Russian FederationA3
TR2019011293T4TürkiyeT4
TR201911293T4TürkiyeT4
LT2470199TLithuaniaT
HRP20191385T1CroatiaT1
PL2470199T3PolandT3
SI2470199T1SloveniaT1
ES2738859T3SpainT3
HUE046598T2HungaryT2
KR102094253B1Republic of KoreaB1
KR20200034828ARepublic of KoreaA
ZA201201435BSouth AfricaB
JP2020090513AJapanA
AU2018204156B2AustraliaB2
RU2731616C2Russian FederationC2
AU2020256322A1AustraliaA1
CY1122128T1CyprusT1
US2021077593A1United States of AmericaA1
KR20210107153ARepublic of KoreaA
EP3482767B1European Patent Office (EPO)B1
JP6952810B2JapanB2
DK3482767T3DenmarkT3
PT3482767TPortugalT
LT3482767TLithuaniaT
JP2022003065AJapanA
PL3482767T3This recordPolandT3
RU2020128994ARussian FederationA
ES2902229T3SpainT3
SI3482767T1SloveniaT1
HRP20211992T1CroatiaT1
EP3998078A1European Patent Office (EPO)A1
HUE057440T2HungaryT2
KR20220104271ARepublic of KoreaA
US2022305091A1United States of AmericaA1
JP7167281B2JapanB2
NO2022054I1NorwayI1
FIC20220051I1FinlandI1
HUS2200050I1HungaryI1
NL301211I1Netherlands (Kingdom of the)I1
JP2023012499AJapanA
NL301211I2Netherlands (Kingdom of the)I2
FR22C1062I1FranceI1
IL266915B1IsraelB1
IL300625AIsraelA
IL266915B2IsraelB2
KR102608546B1Republic of KoreaB1
KR102608551B1Republic of KoreaB1
KR20230164773ARepublic of KoreaA
JP7395693B2JapanB2
Showing 100 of 127